Test Code 2HGA 2-Hydroxyglutaric Acid Chiral Analysis, Quantitative, Random, Urine
Reporting Name
D-,L- 2-Hydroxyglutaric Acid, QN, UPerforming Laboratory
Mayo Clinic Laboratories in RochesterUseful For
Determining type of 2-hydroxyglutaric aciduria by chiral analysis of urine
Method Name
Gas Chromatography Mass Spectrometry (GC-MS)
Necessary Information
1. Age and sex of patient are required.
2. Biochemical Genetics Patient Information (T602) is recommended, but not required, to be filled out and sent with the specimen to aid in the interpretation of test results.
Specimen Required
Supplies: Urine Tube, 10 mL (T068)
Container/Tube: Plastic, 10-mL urine tube
Specimen Volume: 10 mL
Pediatric: If the collection volume appears insufficient, submit as much specimen as possible in a single container; the laboratory will determine if volume is sufficient for test.
Collection Instructions:
1. Collect a random urine specimen (first morning void preferred)
2. No preservative
Specimen Type
UrineSpecimen Minimum Volume
1 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Urine | Frozen (preferred) | 416 days | |
Ambient | 14 days | ||
Refrigerated | 14 days |
Reject Due To
All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.Reference Values
Age |
D-2-hydroxyglutaric acid (mmol/mol creatinine) |
L-2-hydroxyglutaric acid |
0-11 months |
≤14.11 |
≤17.38 |
12-23 months |
≤13.76 |
≤17.03 |
24-35 months |
≤13.38 |
≤16.63 |
3 years |
≤12.96 |
≤16.18 |
4 years |
≤12.20 |
≤15.35 |
5 years |
≤11.40 |
≤14.44 |
6 years |
≤10.56 |
≤13.46 |
7 years |
≤9.71 |
≤12.43 |
8 years |
≤8.93 |
≤11.44 |
9 years |
≤8.21 |
≤10.50 |
10 years |
≤7.56 |
≤9.66 |
11 years |
≤6.99 |
≤8.94 |
12 years |
≤6.47 |
≤8.33 |
13 years |
≤6.01 |
≤7.83 |
14 years |
≤5.60 |
≤7.44 |
15 years |
≤5.23 |
≤7.14 |
16 years |
≤4.91 |
≤6.93 |
17 years |
≤4.63 |
≤6.78 |
18 years |
≤4.40 |
≤6.69 |
19 years |
≤4.21 |
≤6.63 |
20 years |
≤4.07 |
≤6.60 |
21 years |
≤3.96 |
≤6.59 |
22 years |
≤3.88 |
≤6.58 |
23 years |
≤3.81 |
≤6.56 |
24 years |
≤3.76 |
≤6.54 |
25 years |
≤3.71 |
≤6.50 |
26 years |
≤3.67 |
≤6.44 |
27 years |
≤3.63 |
≤6.37 |
28 years |
≤3.59 |
≤6.27 |
29 years |
≤3.56 |
≤6.15 |
30 years |
≤3.54 |
≤6.02 |
31 years |
≤3.52 |
≤5.87 |
32 years |
≤3.50 |
≤5.72 |
33 years |
≤3.49 |
≤5.57 |
34 years |
≤3.48 |
≤5.41 |
35 years |
≤3.46 |
≤5.26 |
36 years |
≤3.45 |
≤5.13 |
37 years |
≤3.43 |
≤5.00 |
38 years |
≤3.42 |
≤4.88 |
39 years |
≤3.40 |
≤4.78 |
40 years |
≤3.39 |
≤4.70 |
41 years |
≤3.37 |
≤4.62 |
42 years |
≤3.35 |
≤4.55 |
43 years |
≤3.33 |
≤4.50 |
44 years |
≤3.30 |
≤4.44 |
45 years |
≤3.28 |
≤4.40 |
46 years |
≤3.24 |
≤4.35 |
47 years |
≤3.21 |
≤4.31 |
48 years |
≤3.17 |
≤4.27 |
49 years |
≤3.13 |
≤4.23 |
50 years |
≤3.10 |
≤4.19 |
51 years |
≤3.07 |
≤4.16 |
52 years |
≤3.04 |
≤4.12 |
53 years |
≤3.01 |
≤4.10 |
54 years |
≤2.99 |
≤4.07 |
55 years |
≤2.97 |
≤4.04 |
56 years |
≤2.95 |
≤4.01 |
57 years |
≤2.93 |
≤3.98 |
58 years |
≤2.91 |
≤3.94 |
59 years |
≤2.89 |
≤3.91 |
60 years |
≤2.87 |
≤3.87 |
61 years |
≤2.85 |
≤3.84 |
62 years |
≤2.83 |
≤3.80 |
63 years |
≤2.79 |
≤3.78 |
64 years |
≤2.76 |
≤3.75 |
65 years |
≤2.71 |
≤3.73 |
66 years |
≤2.67 |
≤3.72 |
67 years |
≤2.61 |
≤3.71 |
68 years |
≤2.56 |
≤3.69 |
69 years |
≤2.50 |
≤3.68 |
70 years |
≤2.44 |
≤3.66 |
71 years |
≤2.38 |
≤3.64 |
72 years |
≤2.32 |
≤3.61 |
73 years |
≤2.26 |
≤3.56 |
74 years |
≤2.21 |
≤3.50 |
75 years |
≤2.16 |
≤3.43 |
76 years |
≤2.10 |
≤3.35 |
77 years |
≤2.05 |
≤3.26 |
78 years |
≤2.00 |
≤3.17 |
79 years |
≤1.94 |
≤3.08 |
80 years |
≤1.89 |
≤2.99 |
81 years |
≤1.84 |
≤2.91 |
82 years |
≤1.80 |
≤2.84 |
83 years |
≤1.75 |
≤2.78 |
84 years |
≤1.71 |
≤2.73 |
85 years |
≤1.68 |
≤2.69 |
86 years |
≤1.65 |
≤2.67 |
87 years |
≤1.64 |
≤2.65 |
88 years |
≤1.63 |
≤2.64 |
≥89 years |
≤1.62 |
≤2.64 |
Interpretation
The values for the D-2-hydroxyglutaric acid and L-2-hydroxyglutaric acid concentrations are reported. The interpretation of the result must be correlated with clinical and other laboratory findings.
Day(s) Performed
Thursday
Report Available
3 to 9 daysTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
83921 x 2
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
2HGA | D-,L- 2-Hydroxyglutaric Acid, QN, U | 79297-8 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
614619 | Interpretation | 79303-4 |
614620 | D-2-Hydroxyglutaric acid | 80100-1 |
614621 | L-2-Hydroxyglutaric acid | 80099-5 |
614622 | Reviewed By | 18771-6 |
Forms
1. Biochemical Genetics Patient Information (T602)
2. If not ordering electronically, complete, print, and send a Biochemical Genetics Test Request (T798) with the specimen.